Scope issues between the BPR and legislation covering veterinary medicines and occupational health and safety

This 60-minute webinar, moderated by David Dillon (Senior Regulatory and Compliance Analyst, Chemical Watch), explored two important product groups where other regulations overlap with the Biocidal Products Regulation (BPR) – followed by a live Q&A.

View the recording below: 

Topics covered in the webinar include:

Regulatory overview between biocidal products, veterinary borderline products and veterinary medicines:

  • Guidance developed under the biocidal products Directive (BPD)
  • Intended uses, marketing claims and regulatory classification
  • Issues with veterinary borderline products and upcoming veterinary medicines regulation

Interfaces between the BPR and occupational safety and health legislation, especially the Carcinogens and Mutagens Directive (CMD), the Chemical Agents Directive (CAD) and the Biological Agents Directive:

  • Risk assessment processes
  • Occupational exposure limits (OELs) versus accepted exposure levels (AELs)
  • Risk management measures
  • Substitution
  • Traceability


  • Cyril Durou, Executive Vice President, Manager Bordeaux Agency, Cehtra
  • Dr Patrick Levy, Director of the Health Business Line and the Health and Product-safety Agency of SOCOTEC Environment, France


  • David Dillon, Senior Regulatory and Compliance Analyst, Chemical Watch